Oppenheimer analyst Leland Gershell outperform rating and $12

Oppenheimer analyst Leland Gershell outperform rating and $12


https://www.marketwatch.com/story/outlook-therapeutics-stock-rockets-on-heavy-volume-again-set-to-triple-in-3-days-2019-05-20?siteid=yhoof2&yptr=yahoo
https://finance.yahoo.com/news/outlook-therapeutics-rallies-150-2-191742290.html?.tsrc=rss
https://www.marketwatch.com/story/outlook-therapeutics-stock-rockets-on-heavy-volume-again-has-more-than-doubled-in-2-days-2019-05-17?siteid=yhoof2&yptr=yahoo
https://seekingalpha.com/article/4265311-outlook-therapeutics-perfect-storm-positive-catalysts-driving-share-price

Buy a Crypto Miner

AdSense